To include your compound in the COVID-19 Resource Center, submit it here.

Medidur fluocinolone acetonide intravitreal implant: Completed Phase III enrollment

pSivida completed enrollment of 150 patients in a double-blind, sham-controlled, Indian Phase III trial

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE